Cantor Fitzgerald analyst Troy Jensen raised the firm’s price target on Protolabs (PRLB) to $51 from $50 and keeps an Overweight rating on the shares. Proto Labs reported better-than-expected revenue and adjusted EPS, and management guidance for Q3 for revenue and adjusted EPS were above consensus estimates, the analyst tells investors in a research note. Proto Labs continues to be one of the most profitable service bureaus, and the stock could outperform if management can effectively cross-sell its Network offering with existing customers and drive higher levels of profitability, Cantor argues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRLB:
- Protolabs upgraded to Buy from Hold at Craig-Hallum
- Proto Labs Reports Record Revenue in Q2 2025
- Proto Labs Inc. Reports Record Revenue in Q2 2025
- Proto Labs: Balancing Strong Performance with Future Challenges – Hold Rating Maintained
- Proto Labs: Strong Q2 Results and Positive Revenue Outlook, But European Performance and Profit Growth Concerns Justify Hold Rating